Skip to main content
. 2017 Mar 30;12(3):e0174114. doi: 10.1371/journal.pone.0174114

Table 4. Overall clinical response to betahistine treatment assessed by physicians and patients.

Overall clinical response Assessed by physicians, n (%) Assessed by patients, n (%)
Visit 2 End of treatment Visit 2 End of treatment
Poor 3 (1.0) 2 (0.7) 3 (1.0) 4 (1.3)
Fair 71 (23.4) 15 (4.9) 69 (22.7) 10 (3.3)
Good 185 (60.9) 162 (53.1) 190 (62.5) 162 (53.1)
Excellent 45 (14.8) 126 (41.3) 42 (13.8) 129 (42.3)
Totala 304b 305 304b 305

a For 60-day treatment group;

b N = 304 due to one patient having a combined Visit 2 and 3, which was only inputted as Visit 3